Clinical Analysis On52Cases Of Previously Untreated Elderly Patients With Acute Myeloid Leukemia

Objective: To analysis of elderly patients with acute myeloid leukemia(AML)clinical features, explore the different treatment options for initial treatment ofrelief.Methods: A retrospective analysis of our hospital in2007May to2009Novemberwere diagnosed in52patients with AML, including male32cases,20cases of female, ageat60～80, the median age was68years old. In52patients,20cases for abandoningtreatment, early death was3cases, the remaining29patients received combinedchemotherapy. According to the individual differences of different chemotherapy regimensin chemotherapy. On receiving chemotherapy for29cases of patients with clinical data,remission induction chemotherapy for clinical summary and analysis. Results:Granulocyte colony-stimulating factor priming regimen in treatment group (CAG andCHG)in10cases, complete remission (CR)rate was60%,8cases in group DA, completeremission (CR)rate was37.5%,6cases in group IA, complete remission (CR)rate50%,2/3dose2cases in group DA, complete remission (CR)rate50%,2/3dose of IA3cases,complete remission (CR)rate33.3%. Conclusion: Elderly AML patients with poorhistologic response to chemotherapy, induction remission rates low, should be thetreatment of choice for active and reasonable, individual chemotherapy.